Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix

Basic Research in Cardiology
Emma RobinsonDavid J Grieve

Abstract

Glucagon-like peptide-1 (GLP-1) is an insulin-releasing hormone clinically exploited for glycaemic control in diabetes, which also confers acute cardioprotection and benefits in experimental/clinical heart failure. We specifically investigated the role of the GLP-1 mimetic, exendin-4, in post-myocardial infarction (MI) remodelling, which is a key contributor to heart failure. Adult female normoglycaemic mice underwent coronary artery ligation/sham surgery prior to infusion with exendin-4/vehicle for 4 weeks. Metabolic parameters and infarct sizes were comparable between groups. Exendin-4 protected against cardiac dysfunction and chamber dilatation post-MI and improved survival. Furthermore, exendin-4 modestly decreased cardiomyocyte hypertrophy/apoptosis but markedly attenuated interstitial fibrosis and myocardial inflammation post-MI. This was associated with altered extracellular matrix (procollagen IαI/IIIαI, connective tissue growth factor, fibronectin, TGF-β3) and inflammatory (IL-10, IL-1β, IL-6) gene expression in exendin-4-treated mice, together with modulation of both Akt/GSK-3β and Smad2/3 signalling. Exendin-4 also altered macrophage response gene expression in the absence of direct actions on cardiac fibroblast diff...Continue Reading

References

May 15, 2003·Endocrinology·Robert GrosMansoor Husain
Jun 5, 2003·The Journal of Biological Chemistry·Don ArnetteMelanie H Cobb
Aug 24, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Rudolf A de BoerYigal M Pinto
Feb 21, 2006·Journal of the American College of Cardiology·Juan Asbun, Francisco J Villarreal
Aug 19, 2008·Archives of Biochemistry and Biophysics·Brian D GreenDavid J Grieve
Nov 11, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·David S H Bell
Nov 20, 2008·Current Protocols in Immunology·Xia ZhangDavid M Mosser
Feb 7, 2009·Journal of the American College of Cardiology·Leo TimmersImo E Hoefer
Feb 21, 2009·Journal of Cellular and Molecular Medicine·C TroidlA Elsässer
May 23, 2009·Pharmacology & Therapeutics·Karen E Porter, Neil A Turner
Aug 18, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Longhu LiShinya Minatoguchi
Dec 30, 2009·The Journal of Clinical Investigation·Norifumi TakedaRyozo Nagai
Feb 5, 2010·Canadian Journal of Physiology and Pharmacology·Christine M HantoucheAnwar B Bikhazi
Mar 9, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Yumei YeYochai Birnbaum
May 22, 2010·Journal of Molecular and Cellular Cardiology·Sandra B HaudekMark L Entman
Jul 20, 2011·Hypertension·Monica L BertoiaCharles B Eaton
Nov 1, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Jamie E MellsFrank A Anania
Sep 3, 2013·The New England Journal of Medicine·Benjamin M SciricaUNKNOWN SAVOR-TIMI 53 Steering Committee and Investigators
Sep 3, 2013·The New England Journal of Medicine·William B WhiteUNKNOWN EXAMINE Investigators
Mar 14, 2014·JACC. Heart Failure·Eugene Braunwald

❮ Previous
Next ❯

Citations

Nov 1, 2015·Biochemical and Biophysical Research Communications·Yue ZhouJiangui He
Jul 7, 2015·BioMed Research International·Wellington Santana da Silva JúniorLuiz Guilherme Kraemer-Aguiar
Nov 24, 2016·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C GuoX Gu
May 19, 2018·American Journal of Physiology. Heart and Circulatory Physiology·David A LiemJiaWei Han
Jan 20, 2016·Current Atherosclerosis Reports·Ashish SarrajuJoshua W Knowles
May 6, 2017·Clinical Science·Mitchel TateRebecca H Ritchie
Jan 5, 2017·Clinical Science·Emilie PastelKatarina Kos
Jul 6, 2017·Journal of Cardiovascular Pharmacology·Panagiotis AlexopoulosNikos E Tsopanoglou
Dec 14, 2018·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Mia StåhleAntti Saraste

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
reverse transcription-PCR
antibody array
protein array

Software Mentioned

Elements
ImageJ
NIS

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.